KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Short term Debt (2016 - 2025)

Bausch Health Companies' Short term Debt history spans 16 years, with the latest figure at $579.0 million for Q3 2025.

  • For Q3 2025, Short term Debt rose 27.81% year-over-year to $579.0 million; the TTM value through Sep 2025 reached $579.0 million, up 27.81%, while the annual FY2024 figure was $2.7 billion, 494.22% up from the prior year.
  • Short term Debt for Q3 2025 was $579.0 million at Bausch Health Companies, down from $879.0 million in the prior quarter.
  • Across five years, Short term Debt topped out at $2.7 billion in Q4 2024 and bottomed at $150.0 million in Q2 2022.
  • The 4-year median for Short term Debt is $451.0 million (2023), against an average of $623.3 million.
  • The largest annual shift saw Short term Debt skyrocketed 494.22% in 2024 before it crashed 47.58% in 2025.
  • A 4-year view of Short term Debt shows it stood at $432.0 million in 2022, then increased by 4.17% to $450.0 million in 2023, then surged by 494.22% to $2.7 billion in 2024, then crashed by 78.35% to $579.0 million in 2025.
  • Per Business Quant, the three most recent readings for BHC's Short term Debt are $579.0 million (Q3 2025), $879.0 million (Q2 2025), and $282.0 million (Q1 2025).